{"schema_version":"secwatch.filing_event.v1","accession":"0001301787-24-000031","form_type":"8-K","ticker":"BXC","cik":"0001301787","company_name":"BlueLinx Holdings Inc.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.016716+00:00","generated_at":"2026-05-30T08:55:27.869078+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BlueLinx Q3 net sales $747M (-8% YoY), diluted EPS $1.87, adjusted EBITDA $37M (4.9% of sales)","bullets":["Net income $16M, diluted EPS $1.87; adjusted EPS $1.95 vs $2.98 a year ago.","Specialty product sales $519M (-7.1% YoY), gross margin 19.4% including $3.5M duty benefit.","Structural product sales $228M (-9.1% YoY), gross margin 11.0% aided by $2.4M inventory write-down sale.","Free cash flow $54M; $526M cash; $61M left on $100M share buyback authorization.","Q4 outlook: specialty gross margin 18-19%, structural 9-10%, daily sales volumes slightly improved."],"urls":{"canonical":"https://secwatch.observer/filing/0001301787-24-000031","json":"https://secwatch.observer/filing/0001301787-24-000031.json","markdown":"https://secwatch.observer/filing/0001301787-24-000031.md","text":"https://secwatch.observer/filing/0001301787-24-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1301787/000130178724000031/0001301787-24-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1301787/000130178724000031/bxc-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:55:27.869078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}